Skip to main content

InStride Health

Boston, United States

InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.

$30.0M raised
Mar 2024
Series B

Top Investors

General Catalyst.406 VenturesValtruisHopelabMass General Brigham Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about InStride Health

How much funding has InStride Health raised?
InStride Health has raised $30.0M in total funding. The most recent round was Series B. The last funding was announced in March 2024.
Who are InStride Health's investors?
InStride Health's investors include General Catalyst, .406 Ventures, Valtruis, Hopelab, Mass General Brigham Ventures.
Where is InStride Health headquartered?
InStride Health is headquartered in Boston, United States.
What does InStride Health do?
InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.
What stage is InStride Health at?
InStride Health is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"InStride Health — Funding & Investors." VCBacked, March 27, 2024, https://www.vcbacked.co/company/instride-health. Accessed June 12, 2026.
APA
VCBacked. (2024). InStride Health — Funding & Investors. Retrieved June 12, 2026, from https://www.vcbacked.co/company/instride-health
Wikipedia (cite web)
{{cite web |title=InStride Health — Funding & Investors |url=https://www.vcbacked.co/company/instride-health |website=VCBacked |access-date=June 12, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .